Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Dr. Soon-Shiong is hopeful the Saudi Arabian FDA's approval of his cancer therapy drug, Anktiva, will lead to widespread ...

What Is Zusduri Used For? Zusduri is used to treat a certain type of recurrent, persistent bladder cancer known as LG-IR-NMIBC. About 75% of people with bladder cancer present with non-muscle invasive ...

The extent of the bladder cancer — how far it has spread — matters. Your care team needs to know if your cancer sits on or in the first lining of your bladder (non-muscle invasive), if it goes into ...

ImmunityBio stock rose 19.8% after FDA meeting on ANKTIVA bladder cancer treatment. Company to submit additional data within ...

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.

Excitement is building as a new treatment for advanced bladder cancer that doubles survival time has been approved for NHS use. The new treatment combination includes enfortumab vedotin (Padcev) and ...

Risk factors are things that raise your chances of getting a disease. There are different types of risk factors such as genetic, biological, lifestyle and exposure. For each person, a mix of these ...